Literature DB >> 17670789

Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells.

Yuichi Ono1, Tomoya Nakatani, Yoshimasa Sakamoto, Eri Mizuhara, Yasuko Minaki, Minoru Kumai, Akiko Hamaguchi, Miyuki Nishimura, Yoko Inoue, Hideki Hayashi, Jun Takahashi, Toshio Imai.   

Abstract

Directed differentiation and purification of mesencephalic dopaminergic (mesDA) neurons from stem cells are crucial issues for realizing safe and efficient cell transplantation therapies for Parkinson's disease. Although recent studies have identified the factors that regulate mesDA neuron development, the mechanisms underlying mesDA neuron specification are not fully understood. Recently, it has been suggested that mesencephalic floor plate (FP) cells acquire neural progenitor characteristics to generate mesDA neurons. Here, we directly examined this in a fate mapping experiment using fluorescence-activated cell sorting (FACS) with an FP cell-specific surface marker, and demonstrate that mesencephalic FP cells have neurogenic activity and generate mesDA neurons in vitro. By contrast, sorted caudal FP cells have no neurogenic potential, as previously thought. Analysis of dreher mutant mice carrying a mutation in the Lmx1a locus and transgenic mice ectopically expressing Otx2 in caudal FP cells demonstrated that Otx2 determines anterior identity that confers neurogenic activity to FP cells and specifies a mesDA fate, at least in part through the induction of Lmx1a. We further show that FACS can isolate mesDA progenitors, a suitable transplantation material, from embryonic stem cell-derived neural cells. Our data provide insights into the mechanisms of specification and generation of mesDA neurons, and illustrate a useful cell replacement approach for Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17670789     DOI: 10.1242/dev.02879

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  129 in total

1.  Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.

Authors:  Emmanouil Metzakopian; Wei Lin; Mali Salmon-Divon; Heidi Dvinge; Elisabet Andersson; Johan Ericson; Thomas Perlmann; Jeffrey A Whitsett; Paul Bertone; Siew-Lan Ang
Journal:  Development       Date:  2012-06-13       Impact factor: 6.868

Review 2.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

3.  Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Authors:  Stina Friling; Elisabet Andersson; Lachlan H Thompson; Marie E Jönsson; Josephine B Hebsgaard; Evanthia Nanou; Zhanna Alekseenko; Ulrika Marklund; Susanna Kjellander; Nikolaos Volakakis; Outi Hovatta; Abdeljabbar El Manira; Anders Björklund; Thomas Perlmann; Johan Ericson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

4.  Too much Sonic, too few neurons.

Authors:  Christopher A Fasano; Lorenz Studer
Journal:  Nat Neurosci       Date:  2009-02       Impact factor: 24.884

5.  Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.

Authors:  Julio Cesar Aguila; Alexandra Blak; Joris van Arensbergen; Amaia Sousa; Nerea Vázquez; Ariane Aduriz; Mayela Gayosso; Maria Paz Lopez Mato; Rakel Lopez de Maturana; Eva Hedlund; Kai-Christian Sonntag; Rosario Sanchez-Pernaute
Journal:  Stem Cells Transl Med       Date:  2014-07-14       Impact factor: 6.940

6.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

7.  Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway.

Authors:  Sangmi Chung; Amanda Leung; Baek-Soo Han; Mi-Yoon Chang; Jung-Il Moon; Chun-Hyung Kim; Sunghoi Hong; Jan Pruszak; Ole Isacson; Kwang-Soo Kim
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

8.  Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.

Authors:  Eva Hedlund; Jan Pruszak; Thomas Lardaro; Wesley Ludwig; Angel Viñuela; Kwang-Soo Kim; Ole Isacson
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

9.  Stem cells in development of therapeutics for Parkinson's disease: a perspective.

Authors:  Jiajie Xi; Su-Chun Zhang
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

10.  Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?

Authors:  Olle Bergman; Anna Håkansson; Lars Westberg; Andrea Carmine Belin; Olof Sydow; Lars Olson; Björn Holmberg; Laura Fratiglioni; Lars Bäckman; Elias Eriksson; Hans Nissbrandt
Journal:  J Neural Transm (Vienna)       Date:  2009-02-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.